1. Home
  2. MRAM vs ACET Comparison

MRAM vs ACET Comparison

Compare MRAM & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRAM
  • ACET
  • Stock Information
  • Founded
  • MRAM 2008
  • ACET 1947
  • Country
  • MRAM United States
  • ACET United States
  • Employees
  • MRAM N/A
  • ACET N/A
  • Industry
  • MRAM Semiconductors
  • ACET Biotechnology: Pharmaceutical Preparations
  • Sector
  • MRAM Technology
  • ACET Health Care
  • Exchange
  • MRAM Nasdaq
  • ACET Nasdaq
  • Market Cap
  • MRAM 114.4M
  • ACET 64.9M
  • IPO Year
  • MRAM 2016
  • ACET N/A
  • Fundamental
  • Price
  • MRAM $6.75
  • ACET $0.76
  • Analyst Decision
  • MRAM Strong Buy
  • ACET Buy
  • Analyst Count
  • MRAM 1
  • ACET 6
  • Target Price
  • MRAM $8.00
  • ACET $6.00
  • AVG Volume (30 Days)
  • MRAM 218.3K
  • ACET 423.1K
  • Earning Date
  • MRAM 07-30-2025
  • ACET 08-12-2025
  • Dividend Yield
  • MRAM N/A
  • ACET N/A
  • EPS Growth
  • MRAM N/A
  • ACET N/A
  • EPS
  • MRAM N/A
  • ACET N/A
  • Revenue
  • MRAM $49,110,000.00
  • ACET N/A
  • Revenue This Year
  • MRAM $9.48
  • ACET N/A
  • Revenue Next Year
  • MRAM $12.85
  • ACET N/A
  • P/E Ratio
  • MRAM N/A
  • ACET N/A
  • Revenue Growth
  • MRAM N/A
  • ACET N/A
  • 52 Week Low
  • MRAM $4.34
  • ACET $0.45
  • 52 Week High
  • MRAM $7.02
  • ACET $1.70
  • Technical
  • Relative Strength Index (RSI)
  • MRAM 62.00
  • ACET 53.73
  • Support Level
  • MRAM $6.70
  • ACET $0.58
  • Resistance Level
  • MRAM $6.94
  • ACET $0.72
  • Average True Range (ATR)
  • MRAM 0.24
  • ACET 0.04
  • MACD
  • MRAM 0.03
  • ACET 0.01
  • Stochastic Oscillator
  • MRAM 74.30
  • ACET 88.89

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: